Global Stakeholder Initiatives

BEST PRACTICES FOR THE TRANSLATION OF PLURIPOTENT STEM CELL-DERIVED THERAPIES (Hall 3G, L3)

Speaker(s)

• 

  Ricardo Baptista, Eng PhD (he/him/his)

  SmartCella, Sweden
• 

  Deborah Hursh, PhD (she/her/hers)

  Hursh Consulting
• 

  Jung-Hyun Kim, PhD

  Ajou University
• 

  Tenneille Ludwig, PhD (she/her/hers)

  WiCell Stem Cell Bank
  WiCell Research Institute, United States
• 

  John Rasko

  Cynata Therapeutics
• 

  Dhruv Sareen, PhD

  Cedars-Sinai Medical Center
• 

  Glyn Stacey, PhD

  International Stem Cell and Banking Initiative, United Kingdom

Presentations:

• STARTING THE PROCESS: SELECTION AND BANKING
  

  Speaker: Tenneille Ludwig, PhD (she/her/hers) – WiCell Research Institute

  Speaker: Jung-Hyun Kim, PhD – Ajou University

  Speaker: Glyn Stacey, PhD – International Stem Cell and Banking Initiative
• MATERIALS, DEVICES, AND MANUFACTURING
  

  Speaker: Ricardo Baptista, Eng PhD (he/him/his) – SmartCella

  Speaker: Dhruv Sareen, PhD – Cedars-Sinai Medical Center
• PRODUCT TESTING: PRECLINICAL DEVELOPMENT AND CLINICAL TRIALS
  

  Speaker: John Rasko – Cynata Therapeutics
• REGULATORY CONSIDERATIONS
  

  Speaker: Deborah Hursh, PhD (she/her/hers) – Hursh Consulting